TMEM230

transmembrane protein 230

Basic information

Region (hg38): 20:5068232-5113087

Previous symbols: [ "C20orf30" ]

Links

ENSG00000089063NCBI:29058OMIM:617019HGNC:15876Uniprot:Q96A57AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Parkinson disease (Moderate), mode of inheritance: Semidominant

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TMEM230 gene.

  • not provided (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TMEM230 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
8
clinvar
3
clinvar
12
missense
1
clinvar
18
clinvar
3
clinvar
2
clinvar
24
nonsense
0
start loss
2
clinvar
1
clinvar
3
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
3
3
non coding
1
clinvar
4
clinvar
9
clinvar
14
Total 1 0 23 16 14

Highest pathogenic variant AF is 0.0000131

Variants in TMEM230

This is a list of pathogenic ClinVar variants found in the TMEM230 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
20-5069280-T-G TMEM230-related disorder Likely benign (Jan 11, 2021)3039663
20-5069330-C-T TMEM230-related disorder Likely benign (Nov 03, 2020)3048152
20-5100831-C-T not specified Uncertain significance (Sep 25, 2023)2071795
20-5100832-G-A Benign (Nov 22, 2023)2046219
20-5100843-G-A Uncertain significance (Jun 10, 2021)1432566
20-5100857-G-A Likely benign (Jun 26, 2022)2143553
20-5100861-C-A not specified Uncertain significance (Sep 14, 2022)2312112
20-5100862-G-C not specified Uncertain significance (Dec 21, 2022)2338999
20-5100892-G-C Uncertain significance (Sep 27, 2022)2032928
20-5100921-C-A Pathogenic (Sep 04, 2023)243014
20-5100922-G-T Likely benign (Jun 27, 2023)2991752
20-5100928-C-G not specified Uncertain significance (Mar 08, 2024)3179205
20-5100946-A-C Likely benign (Aug 13, 2022)1945464
20-5101102-C-G Benign (May 16, 2021)1247220
20-5101105-CA-C Benign (May 23, 2021)1230102
20-5106074-GACAA-G Benign (May 17, 2021)1291916
20-5106074-GACAAAC-G Benign (May 16, 2021)1230424
20-5106074-GACAAACAC-G Benign (May 19, 2021)1245471
20-5106074-GACAAACACAC-G Benign (May 21, 2021)1288935
20-5106076-CAA-C Benign (May 16, 2021)1182099
20-5106078-A-AAC Benign (May 17, 2021)1275019
20-5106078-A-AACAC Benign (May 23, 2021)1265588
20-5106178-G-A Likely benign (Jan 26, 2024)1546314
20-5106196-TGATGTAGCCTGACAGCAGGAGGGAGCCTATAATAATGAGAAAGGCGCCAATCAAAAACAGCACAGTGGCAAGTGCGATGGCCTTATAAGGGATCTTAGGAGGGGTTTTCTTAAACTGGAAGAGAAATAGAGATGAAAAAGACAACGAAGAACATTAATGCAAATACCTGGGTTCAAACATTTAATTAATTATTTGTAATTTTTATGTTTTTGTTTGTTTGTTTTGAGATGGAGTTTCGTTCTTGTTGCCCAGGCTAGAGAGCAATGGCGTGATCTTGGCTCACTGCAACCTCTGCCTCCTGGATTCAAGTGATTCTCCTGTCTCAGCCTCCTGAGCAGCTGGGGTTACAGGTGCCCGCCACTACACCCAGCTAATTTTTTTGGTATTTTTAGTAGAGACAGGGTTTCACCTTGTTGACCTGGCTGGGCTTGAACTCCTGACCTCAGGTGATCCGCCCGCCTCGGCCTCCCAAAGTGCTGGCATTACAGGCGTGAGCCACCGCGCCCGGCCTAATTTTTATGATTTTAGAGACGGAGTCTTGCTCTATCACCCAGGCTGGAGTGCAGTGGTGCAATTACAGCTCATTGCAGCCTCGAACTCCTGGGCTCAAGCAATTCTCTTGCCTCATCCTCTCAAGTAGCTGGGACTACAAGTATACGTCACCATGCCCAGCTAATTTTTAAATTTTTCTGTAGAGACGAGGTCTCACTATGTTGCCCAGGGTGGTCTCCAACTCCTGGGCTCAAGGGAGTCCTTCCACCTCTGCCTCCCAAAGTGCTGGGATTACAGGTATAAGCCATCAAGCCCAGTCTCAAACACTTTAAAACAGGGAGGAGAGCTCGCACCTGTAATCCCAGCAATGTGGGAGGCTGAGGCAGGCGGATCACTTGAGTTCAGGAGTTTGAGACCAGCCTGAGCAACATGGTGAAACCTCGTCTCTACAAAAAATACAAAAATTAGCC-T Uncertain significance (Jan 21, 2022)2088969
20-5106202-A-G not specified Uncertain significance (Jan 23, 2024)3179204

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TMEM230protein_codingprotein_codingENST00000342308 513264
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0001810.4801257270201257470.0000795
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.3608493.80.8950.000004901139
Missense in Polyphen1021.5320.46442278
Synonymous0.4443538.50.9090.00000204390
Loss of Function0.32566.920.8672.97e-798

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00006180.0000615
Ashkenazi Jewish0.000.00
East Asian0.0002720.000272
Finnish0.000.00
European (Non-Finnish)0.00004410.0000439
Middle Eastern0.0002720.000272
South Asian0.0002610.000261
Other0.0001640.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Involved in trafficking and recycling of synaptic vesicles. {ECO:0000269|PubMed:27270108}.;
Disease
DISEASE: Parkinson disease (PARK) [MIM:168600]: A complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability. Additional features are characteristic postural abnormalities, dysautonomia, dystonic cramps, and dementia. The pathology of Parkinson disease involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. The disease is progressive and usually manifests after the age of 50 years, although early-onset cases (before 50 years) are known. The majority of the cases are sporadic suggesting a multifactorial etiology based on environmental and genetic factors. However, some patients present with a positive family history for the disease. Familial forms of the disease usually begin at earlier ages and are associated with atypical clinical features. {ECO:0000269|PubMed:27270108}. Note=The gene represented in this entry may be involved in disease pathogenesis. Genetic variants in TMEM230 and DNAJC13 have been found in the same large multigenerational family with adult-onset Parkinson disease. The pathological role of each gene and therefore the exact molecular basis of the disease is unclear. {ECO:0000305|PubMed:27270108}.;

Recessive Scores

pRec
0.0918

Haploinsufficiency Scores

pHI
0.158
hipred
N
hipred_score
0.306
ghis
0.613

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.114

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Tmem230
Phenotype

Gene ontology

Biological process
synaptic vesicle transport
Cellular component
early endosome;late endosome;autophagosome;endoplasmic reticulum;trans-Golgi network;synaptic vesicle;integral component of membrane;cell junction;recycling endosome
Molecular function